Moreover, since B16.F1 melanoma cells show low metastatic capability, whether the final outcome of these opposite effects in migration and MMP-2 and MMP-9 activities would be pro- or anti-metastatic needs to be addressed. This evidence concerns the gene MMP2 and melanoma.